Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Breast Neoplasms and PPM1D[original query] |
---|
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature 2012 Dec . Ruark E, Snape K, Humburg P, Loveday C, Bajrami I, Brough R, Rodrigues DN, Renwick A, Seal S, Ramsay E, Duarte SD, Rivas MA, Warren-Perry M, Zachariou A, Campion-Flora A, Hanks S, Murray A, Pour NA, Douglas J, Gregory L, Rimmer A, Walker NM, Yang TP, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Eccles D, Evans DG, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Gore M, Houlston R, Brown MA, Caufield MJ, Deloukas P, McCarthy MI, Todd JA, Turnbull C, Reis-Filho JS, Ashworth A, Antoniou AC, Lord CJ, Donnelly P, Rahman N |
PPM1D mutations in circulating white blood cells and the risk for ovarian cancer. Journal of the National Cancer Institute 2013 Nov . Akbari MR, Lepage P, Rosen B, McLaughlin J, Risch H, Minden M, Narod SA |
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma. JAMA oncology 2016 Feb . Swisher Elizabeth M, Harrell Maria I, Norquist Barbara M, Walsh Tom, Brady Mark, Lee Ming, Hershberg Robert, Kalli Kimberly R, Lankes Heather, Konnick Eric Q, Pritchard Colin C, Monk Bradley J, Chan John K, Burger Robert, Kaufmann Scott H, Birrer Michael |
Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer. Clinical breast cancer 2017 12 18 (4): e643-e650. Inoue Yuka, Yamashita Nami, Kitao Hiroyuki, Tanaka Kimihiro, Saeki Hiroshi, Oki Eiji, Oda Yoshinao, Tokunaga Eriko, Maehara Yoshihi |
Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy. PloS one 2019 14 (6): e0217521. Kim Borahm, Won Dongju, Lee Seung-Tae, Choi Jong R |
Detectible mosaic truncating PPM1D mutations, age and breast cancer risk. Journal of human genetics 2019 Mar . Machiela Mitchell J, Myers Timothy A, Lyons Christopher J, Koster Roelof, Figg William D, Colli Leandro M, Jessop Lea, Ahearn Thomas U, Freedman Neal D, García-Closas Montserrat, Chanock Stephen |
Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis. Journal of geriatric oncology 2019 Sep . Slavin Thomas P, Sun Can-Lan, Chavarri-Guerra Yanin, Sedrak Mina S, Katheria Vani, Castillo Danielle, Herzog Josef, Dale William, Hurria Arti, Weitzel Jeffrey |
Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer. Cancers 2020 4 12 (4): . Lhotova Klara, Stolarova Lenka, Zemankova Petra, Vocka Michal, Janatova Marketa, Borecka Marianna, Cerna Marta, Jelinkova Sandra, Kral Jan, Volkova Zuzana, Urbanova Marketa, Kleiblova Petra, Machackova Eva, Foretova Lenka, Hazova Jana, Vasickova Petra, Lhota Filip, Koudova Monika, Cerna Leona, Tavandzis Spiros, Indrakova Jana, Hruskova Lucie, Kosarova Marcela, Vrtel Radek, Stranecky Viktor, Kmoch Stanislav, Zikan Michal, Macurek Libor, Kleibl Zdenek, Soukupova Ja |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: